| Literature DB >> 35155546 |
Hassan Al-Thani1, Ahmed Faidh Ramzee1, Ammar Al-Hassani1, Gustav Strandvik1, Ayman El-Menyar2,3.
Abstract
BACKGROUND: We aimed to study the presentation, management, and outcomes of patients with a pancreatic traumatic injury.Entities:
Keywords: blunt abdomen trauma; injury; pancreas; trauma; visceral
Year: 2022 PMID: 35155546 PMCID: PMC8831377 DOI: 10.3389/fsurg.2021.771121
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Demographics, clinical presentation, associated injuries, procedures, complications and outcomes in patients sustained pancreatic injury (n = 71).
|
|
|
|
|
|---|---|---|---|
| 30.8 ± 12.2 |
| 25 (35.2%) | |
|
| 69 (97.2%) |
| 27 (38.0%) |
|
|
| 22 (31.0%) | |
| Blunt | 65 (91.5%) |
| 26 (36.6%) |
| Penetrating | 6 (8.5%) | Intubated ETT | 44 (62.0%) |
| 14 (3–15) | CT scan abdomen | 71 (100%) | |
|
| 84 (13–2,057) | FAST (positive) | 34 (47.9%) |
|
| 53 (8–1,107) |
| |
|
| Chest tube insertion | 36 (50.7%) | |
| Head | 30 (42.3%) | Exploratory laparotomy | 37 (52.1%) |
| Lung contusion | 24 (33.8%) | Open reduction internal fixation | 12 (16.9%) |
| Pneumothorax | 20 (28.2%) | Spinal surgery | 3 (4.2%) |
| Hemothorax | 13 (18.3%) | Thoracotomy | 4 (5.6%) |
| Hemo-pneumothorax | 6 (8.5%) |
| 8 (11.3%) |
| Rib fracture | 27 (38.0%) | Collection had CT-guided drainage | 4 (50.0%) |
| Spleen | 23 (32.4%) | Pancreatitis | 2 (25.0%) |
| Liver | 21 (29.6%) | Pseudocyst | 1 (12.5%) |
| Small Bowel | 8 (11.3%) | Pancreatic cutaneous fistula | 1 (12.5%) |
| Mesentery | 11 (15.5%) |
| 14 (1–61) |
| Kidney | 11 (15.5%) |
| 6 (1–39) |
| Stomach | 5 (7.0%) |
| 8 (1–30) |
| Mesenteric vein | 3 (4.2%) | Blood transfusion | 51 (71.8%) |
| Inferior vena cava | 1 (1.4%) | Blood units transfused | 8 (1–32) |
| Aortic injury | 0 (0.0%) |
| |
| Diaphragmatic injury | 3 (4.2%) | Wound Infection | 11 (15.5%) |
| Retroperitoneal hematoma | 18 (25.4%) | Pneumonia | 11 (15.5%) |
|
| Acute respiratory distress syndrome | 5 (7.0%) | |
| Head AIS | 4.3 ± 0.9 | Sepsis | 9 (12.7%) |
| Chest AIS | 2.9 ± 0.7 | Acute renal failure | 3 (4.2%) |
| Abdomen AIS | 2.9 ± 0.9 | Coagulopathy | 1 (1.4%) |
| Pelvis AIS | 2.3 ± 0.6 |
| 22 (31.0%) |
| Injury severity score | 27.2 ± 14.5 | ||
|
| 19 (26.8%) | ||
|
| 56 (78.9%) | ||
|
| 2 (2.8%) | ||
|
| 1 (1.4%) |
20 head injury, 1 associated vascular injury, 1 multiorgan failure.
Figure 1Illustration of pancreatic injury grades (I–V).
Demographics, clinical presentation and associated injuries by pancreatic injury scale.
|
|
|
|
|
| |
|---|---|---|---|---|---|
| 29.5 ± 12.4 | 34.5 ± 11.7 | 20.0 ± 10.9 | 28.8 ± 8.2 | 0.10 | |
|
| 33 (97.1%) | 27 (96.4%) | 4 (100%) | 5 (100%) | 0.95 |
|
| 14 (3–15) | 14 (3–15) | 15 (15–15) | 15 (3–15) | 0.19 |
|
| 59 (13–737) | 137 (14–624) | 747 (268–1,191) | 674 (84–2,057) | 0.001 |
|
| 43 (8–394) | 58.5 (15–254) | 237 (72–462) | 249 (40–1,107) | 0.006 |
|
| |||||
| Head | 16 (47.1%) | 13 (46.4%) | 1 (25.0%) | 0 (0.0%) | 0.19 |
| Thoracic | 21 (61.8%) | 13 (46.4%) | 3 (75.0%) | 3 (60.0%) | 0.54 |
| Intraabdominal | 26 (76.5%) | 21 (75.0%) | 3 (75.0%) | 4 (80.0%) | 0.99 |
|
| 4.7 ± 0.9 | 4.0 ± 0.9 | 3.0 ± 0.0 | 0.0 ± 0.0 | 0.06 |
|
| 3.0 ± 0.6 | 2.8 ± 0.8 | 2.7 ± 0.6 | 3.0 ± 0.0 | 0.67 |
|
| 2.8 ± 1.0 | 2.9 ± 0.9 | 3.0 ± 0.8 | 3.6 ± 0.9 | 0.46 |
|
| 31.3 ± 15.4 | 24.5 ± 13.4 | 19.0 ± 8.9 | 21.6 ± 11.4 | 0.12 |
|
| 21(61.8%) | 19 (67.9%) | 1 (25.0%) | 3 (60.0%) | 0.42 |
| 14 (41.2%) | 13 (46.4%) | 3 (75.0%) | 4 (80.0%) | 0.63 | |
|
| 15 (44.1%) | 15 (53.6%) | 2 (50.0%) | 5 (100%) | 0.13 |
|
| 11 (1–61) | 16.5 (1–57) | 36.5 (21–56) | 19 (19–40) | 0.03 |
|
| 5 (1–39) | 10 (1–20) | 12 (1–30) | 7 (1–16) | 0.88 |
|
| 6 (1–26) | 8 (1–13) | 30 (30–30) | 3 (3–6) | 0.26 |
|
| 26 (76.5%) | 20 (71.4%) | 2 (50.0%) | 3 (60.0%) | 0.64 |
|
| 9.5 (2–26) | 6 (1–32) | 16.5 (1–32) | 10 (10–16) | 0.63 |
|
| 14 (41.2%) | 7 (25.0%) | 1 (25.0%) | 0 (0.0%) | 0.21 |
Figure 2Examples of radiologic findings of pancreatic injury in the study cohort using CT scan and MRI. (A) Axial CT in a patient with pancreatic laceration noted at the superior aspect of the body anterior to the spine involving approximately 50% of pancreatic craniocaudal dimension (white arrows), (B) Axial MRI (same finding) T2: the junction between the head and body of the pancreas shows no enhancement in the dynamic phase representing pancreatic contusion. The pancreatic duct adjacent to the contusion area displays focal dilatation without ductal transection. (C) Axial CT shows pseudocyst.
Pancreatic injury by Glasgow coma scale.
|
|
|
| |
|---|---|---|---|
|
| 12 (27.3%) | 13 (48.1%) | 0.07 |
|
| 21.3 ± 12.1 | 37.0 ± 12.7 | 0.001 |
|
| 36 (81.8%) | 26 (96.3%) | 0.07 for all |
|
| 8 (18.2%) | 1 (3.7%) | |
|
| 25 (56.8%) | 12 (44.4%) | 0.31 |
|
| 17 (1–61) | 9 (1–57) | 0.04 |
|
| 5.5 (1–39) | 9 (1–35) | 0.81 |
|
| 8 (1–30) | 7 (1–25) | 0.58 |
|
| |||
| Wound Infection | 9 (20.5%) | 2 (7.4%) | 0.14 |
| Pneumonia | 6 (13.6%) | 5 (18.5%) | 0.58 |
| Acute respiratory distress syndrome | 2 (4.5%) | 3 (11.1%) | 0.29 |
| Sepsis | 4 (9.1%) | 5 (18.5%) | 0.24 |
| Acute renal failure | 1 (2.3%) | 2 (7.4%) | 0.29 |
| Multiorgan failure | 1 (2.3%) | 1 (3.7%) | 0.72 |
| Coagulopathy | 1 (2.3%) | 0 (0.0%) | 0.43 |
|
| 4 (9.1%) | 18 (66.7%) | 0.001 |
Pancreatic injury with and without shock.
|
|
|
| |
|---|---|---|---|
| 32 (69.9%) | 12 (48.0%) | 0.07 for all | |
| 14 (30.4%) | 13 (52.0%) | ||
|
| 23.2 ± 13.6 | 34.6 ± 13.2 | 0.001 |
|
| 40 (87.0%) | 22 (88.0%) | 0.90 for all |
|
| 6 (13.0%) | 3 (12.0%) | |
|
| 24 (52.2%) | 13 (52.0%) | 0.98 |
|
| 16 (1–61) | 11 (1–57) | 0.44 |
|
| 5.5 (1–39) | 8.5 (1–29) | 0.55 |
|
| 8 (1–30) | 6 (1–22) | 0.43 |
|
| |||
| Wound Infection | 6 (13.0%) | 5 (20.0%) | 0.43 |
| Pneumonia | 4 (8.7%) | 7 (28.0%) | 0.07 |
| Acute respiratory distress syndrome | 5 (10.9%) | 0 (0.0%) | 0.08 |
| Sepsis | 5 (10.9%) | 4 (16.0%) | 0.53 |
| Acute renal failure | 3 (6.5%) | 0 (0.0%) | 0.19 |
| Multiorgan failure | 2 (4.3%) | 0 (0.0%) | 0.29 |
| Coagulopathy | 0 (0.0%) | 1 (4.0%) | 0.17 |
|
| 10 (21.7%) | 12 (48.0%) | 0.02 |
Pancreatic injury by severity of injury.
|
|
|
| |
|---|---|---|---|
| 2 (10.5%) | 23 (44.2%) | 0.004 for all | |
| 17 (89.5%) | 27 (51.9%) | ||
|
| 15 (78.9%) | 47 (90.4%) | 0.20 for all |
|
| 4(21.1%) | 5(9.6%) | |
|
| 2 (10.5%) | 23 (44.2%) | 0.01 |
|
| 10 (52.6%) | 27 (51.9%) | 0.95 |
|
| 19 (1–56) | 13 (1–61) | 0.45 |
|
| 4 (1–16) | 8.5 (1–39) | 0.09 |
|
| 3.5 (1–8) | 8 (1–30) | 0.17 |
|
| |||
| Wound Infection | 4 (21.1%) | 7 (13.5%) | 0.43 |
| Pneumonia | 0 (0.0%) | 11 (21.2%) | 0.07 |
| Acute respiratory distress syndrome | 0 (0.0%) | 5 (9.6%) | 0.16 |
| Sepsis | 1 (5.3%) | 8 (15.4%) | 0.25 |
| Acute renal failure | 0 (0.0%) | 3 (5.8%) | 0.28 |
| Multiorgan failure | 0 (0.0%) | 2 (3.8%) | 0.38 |
| Coagulopathy | 0 (0.0%) | 1 (1.9%) | 0.54 |
|
| 0 (0.0%) | 22 (42.3%) | 0.001 |
Figure 3Management and outcomes based on the pancreatic injury grade.